GLOBAL CAUSE | An article sponsored by REPAIR takes a close look at UK and Sweden, who are pioneering innovative new subscription approaches to address the current market failures by using pull incentives to ensure we have a pipeline of drugs to address the antibiotic-resistant bacteria crisis.